FRONTIER Research Group's Avatar

FRONTIER Research Group

@frontier-usyd

The FRONTIER Research Group is the largest specialist #frontotemporaldementia research clinic in Australia. Since 2007, we have specialised in the diagnosis, prognosis, and care of people with #FTD and related conditions. #endFTD https://frontierftd.org

185
Followers
227
Following
62
Posts
27.11.2024
Joined
Posts Following

Latest posts by FRONTIER Research Group @frontier-usyd

@ppaphasiaawareness.bsky.social
@brainandmindcentre.bsky.social
@utas.edu.au
@sydney.edu.au

27.02.2026 02:14 πŸ‘ 0 πŸ” 0 πŸ’¬ 0 πŸ“Œ 0
Post image

Primary Progressive Aphasia Awareness Day Australia 2026

Free webinar: Friday 10 April, 12:00–1:30pm AEST (Zoom)
Hear from specialist clinicians on how early intervention supports people with PPA, including younger‑onset, to keep living well and doing what matters.

Register: bit.ly/PPAAwareness...

27.02.2026 02:14 πŸ‘ 2 πŸ” 1 πŸ’¬ 1 πŸ“Œ 0
Preview
Let us Grow: Life, Creativity and Connection Attend this free webinar for insights from people who have living experience with young onset dementia and how they challenge themselves to live their best life

YOD‑SIG is hosting its first 2026 webinar on 12 March, 12:30–1:30pm AEDT.

Let us Grow explores how creative and inclusive activities can support people with young onset dementia to live meaningful, connected lives.

Register: events.humanitix.com/let-us-grow-...

#YOD #dementia

27.02.2026 00:46 πŸ‘ 0 πŸ” 0 πŸ’¬ 0 πŸ“Œ 0
Preview
Finding Voice Through Loss: how a gift is empowering dementia care A widow’s gift to the Brain and Mind Centre is supporting vital communication therapy for people with Primary Progressive Aphasia, transforming personal loss into lasting impact for dementia care and ...

We’re pleased to share the personal story of SiΓ’n Jarrett. Her generous philanthropy has been instrumental in supporting the provision of speech therapy to so many through FRONTIER’s Speech Pathology Clinic, the PPA Communication Project.

go.sydney.edu.au/aenRtO

@brainandmindcentre.bsky.social

26.02.2026 06:14 πŸ‘ 4 πŸ” 2 πŸ’¬ 0 πŸ“Œ 0
Post image

Some behaviors related to FTD can lead to unexpected interactions with the criminal justice system. This month’s Quick Question asks whether you or your loved one have experienced this. Share your voice: ftdregistry.org/quick-questi...

#endFTD

18.02.2026 20:01 πŸ‘ 1 πŸ” 1 πŸ’¬ 0 πŸ“Œ 0
FTDToolkit A novel online platform to monitor symptom progression in Frontotemporal Dementia and carers’ wellbeing

Professor Eneida Mioshi and her team at @uniofeastanglia.bsky.social (UK) are developing a free, online intervention designed to support family carers of people living with #frontotemporaldementia (FTD). To participate or learn more about the program, visit ftdtoolkit.org

#endFTD

19.02.2026 04:30 πŸ‘ 2 πŸ” 2 πŸ’¬ 0 πŸ“Œ 0
Post image

πŸ“£ The ABI Communication Lab is excited to invite you to our next Sydney Aphasia Social Group event! πŸ’¬

πŸ—“ Tuesday, 24 February 2026
⏰ 11:00 AM – 1:00 PM
πŸ“ Level 4, Susan Wakil Health Building, The University of Sydney

πŸ‘‰ Register here: events.humanitix.com/sydney-aphas...

05.02.2026 01:00 πŸ‘ 1 πŸ” 1 πŸ’¬ 0 πŸ“Œ 0
Preview
Snowy Valleys Council 2026 Australia Day Awards Announced The 2026 Snowy Valleys Council Australia Day Award recipients were announced at a special dinner ceremony held on Saturday 24 January, with invited finalist nominees joining Councillors and dignitarie...

Congratulations to Jane Dean on being named the 2026 Snowy Valleys Citizen Achievement Award! Jane, Stephen, and their family have made an extraordinary contribution to raising awareness and funds for #FTD research within the Tumut community. #endFTD

www.snowyvalleys.nsw.gov.au/News-Media/S...

30.01.2026 04:26 πŸ‘ 2 πŸ” 1 πŸ’¬ 0 πŸ“Œ 0

It's an incredible achievement! Please pass on our congratulations to Henry!

29.01.2026 00:21 πŸ‘ 1 πŸ” 0 πŸ’¬ 0 πŸ“Œ 0
Preview
Modeling contributions of cognition and apathy to functional impairment in younger‐onset dementia INTRODUCTION Overlaps in symptom presentation limits the capacity to predict functional impairment and future care needs in younger-onset dementia syndromes. METHODS A general additive model (GAM)...

New paper by @samuelwarren.bsky.social and colleagues,

Modeling contributions of cognition and apathy to functional impairment in younger-onset dementia

doi.org/10.1002/dad2...

@alzdemjournals.bsky.social
@muireannirish.bsky.social
@brainandmindcentre.bsky.social
@sydney.edu.au

#endFTD

21.01.2026 22:40 πŸ‘ 5 πŸ” 2 πŸ’¬ 0 πŸ“Œ 0
Preview
Understanding the multifaceted nature of quality of life in dementia using a transdiagnostic network analysis approach Efforts to improve quality of life (QOL) in dementia depend on its accurate conceptualization and assessment. We employed a data-driven network approach to examine the structure of relationships be...

New paper by @lauradewitte.bsky.social & Candy Cheung

Understanding the multifaceted nature of quality of life in dementia using a transdiagnostic network analysis approach

doi.org/10.1080/1360...

@muireannirish.bsky.social
@tandfresearch.bsky.social
@brainandmindcentre.bsky.social
@sydney.edu.au

21.01.2026 03:06 πŸ‘ 5 πŸ” 1 πŸ’¬ 0 πŸ“Œ 0

Well done!

04.01.2026 22:38 πŸ‘ 1 πŸ” 0 πŸ’¬ 0 πŸ“Œ 0
Image displaying a laboratory scene with two individuals working, coinciding with an announcement 'GemVax & Kael Announces Results from Phase 2 PSP Study'

Image displaying a laboratory scene with two individuals working, coinciding with an announcement 'GemVax & Kael Announces Results from Phase 2 PSP Study'

GemVax & KAEL report positive safety and tolerability data for its Phase 2 trial for GV1001 in people with #PSP. The trial also showed some potential efficacy for the drug to slow disease progression.

➑️ Click here to learn more: https://bit.ly/44qUxcM

19.12.2025 23:41 πŸ‘ 4 πŸ” 1 πŸ’¬ 0 πŸ“Œ 0
Post image

Our 2025 group photo. Big smiles, big plans for the year ahead.

#frontotemporaldementia #primaryprogressiveaphasia #ftd #ftld #ppa #endFTD

@brainandmindcentre.bsky.social
@sydney.edu.au

17.12.2025 21:51 πŸ‘ 2 πŸ” 0 πŸ’¬ 0 πŸ“Œ 0
Post image

The #UniversityofSydney SPEECH Clinic is now taking on clients interested in the 10-week convers-ABI-lity program!

The SPEECH Clinic will be taking on new adult clients and will be offering assessment and treatment sessions.

If interested, please reach out to petra.avramovic@sydney.edu.au

10.12.2025 01:00 πŸ‘ 1 πŸ” 1 πŸ’¬ 0 πŸ“Œ 0
Post image

The Nature Partner Journals Dementia are looking for essays from clinicians and researchers who have experience with all forms of Dementia. The essays will be collated together to create "The Human Connection". Learn more here: ow.ly/9yrK50XAyH1 #researchers #journal #essays #personalexperiences

09.12.2025 11:45 πŸ‘ 3 πŸ” 2 πŸ’¬ 0 πŸ“Œ 0
Preview
Irene and LottieΒ findΒ the rightΒ support at a challenging time Irene and Lottie find essential support and resources through Carer Conversations to navigate the challenges of caring for a loved one with Frontotemporal Dementia.

We’re deeply grateful to #DementiaSupportAustralia and #AFTDA for creating Carer Conversations, a lifeline for people across Australia who are supporting someone living with #frontotemporaldementia.

www.dementia.com.au/resource-hub...

#endFTD

03.12.2025 23:54 πŸ‘ 2 πŸ” 0 πŸ’¬ 0 πŸ“Œ 0

This is a great initiative!

30.11.2025 22:27 πŸ‘ 2 πŸ” 0 πŸ’¬ 1 πŸ“Œ 0

What a great initiative!

26.11.2025 23:54 πŸ‘ 0 πŸ” 0 πŸ’¬ 0 πŸ“Œ 0
Promotional image for a webinar titled "FTD Research 2025: Paving the Path Towards Effective Treatments" scheduled for December 10, 2025, featuring Penny Dacks, AFTD Chief Scientific Officer and FTD Disorders Registry President, and Chiadi Onyike, AFTD's Medical Advisory Council Chair and Johns Hopkins University's Frontotemporal Dementia and Young-Onset Dementias Clinic Director. Sponsored by Passage Bio.

Promotional image for a webinar titled "FTD Research 2025: Paving the Path Towards Effective Treatments" scheduled for December 10, 2025, featuring Penny Dacks, AFTD Chief Scientific Officer and FTD Disorders Registry President, and Chiadi Onyike, AFTD's Medical Advisory Council Chair and Johns Hopkins University's Frontotemporal Dementia and Young-Onset Dementias Clinic Director. Sponsored by Passage Bio.

Join us for an inside look at the progress shaping FTD research. On 12/10 at 3 pm, AFTD experts Dr. Penny D. and Dr. Chiadi O. will discuss advancements from 2025 & the momentum driving us toward effective treatments in the years ahead. Sponsored by Passage Bio

Register now: https://bit.ly/4rfNmOq

20.11.2025 21:09 πŸ‘ 2 πŸ” 2 πŸ’¬ 0 πŸ“Œ 0

Thank you for the great work that you do.

19.11.2025 21:19 πŸ‘ 0 πŸ” 0 πŸ’¬ 0 πŸ“Œ 0
Post image Post image Post image Post image

Another successful FRONTIER Charity Golf Day in Tumut! We’re deeply grateful to the Tumut community and the Dean family for their incredible support. Your support makes it possible for us to advance our understanding and treatment of #FTD.

#endFTD #PPA

@brainandmindcentre.bsky.social

16.11.2025 05:59 πŸ‘ 3 πŸ” 0 πŸ’¬ 0 πŸ“Œ 0

Congratulations, Rebecca!

03.11.2025 02:46 πŸ‘ 1 πŸ” 0 πŸ’¬ 1 πŸ“Œ 0

This is an excellent article. Thanks for sharing.

03.11.2025 02:43 πŸ‘ 1 πŸ” 0 πŸ’¬ 0 πŸ“Œ 0
Promotional banner for Alector Clinical Trial Results Townhall on Thursday, November 6, 2025, at 3:00 p.m. ET, featuring Carmela Tartaglia and Penny Dacks from The Association for Frontotemporal Degeneration. Includes headshots and titles of the speakers.

Promotional banner for Alector Clinical Trial Results Townhall on Thursday, November 6, 2025, at 3:00 p.m. ET, featuring Carmela Tartaglia and Penny Dacks from The Association for Frontotemporal Degeneration. Includes headshots and titles of the speakers.

Results from Alector Therapeutics’ Phase 3 trial for Latozinemab (AL001), designed for people with FTD caused by GRN variants, have raised important questions for many. Join us on Nov. 6 for a live discussion about what these results mean and what’s next for FTD research: https://bit.ly/3Lw3Sco

30.10.2025 15:49 πŸ‘ 3 πŸ” 2 πŸ’¬ 0 πŸ“Œ 0
Preview
ISFTD Webinar on AI in FTD: From Neuropathology to MRI to Clinic - ISFTD

Join ISFTD's Webinar on AI in FTD: From Neuropathology to MRI to Clinic

Wednesday, 29th October, 2025 at 11:00 AM EST.

www.isftd.org/events/webin...

#endFTD
#ISFTD

29.10.2025 06:17 πŸ‘ 2 πŸ” 0 πŸ’¬ 0 πŸ“Œ 0
Preview
Training Courses and Events Upcoming Better Conversations events are advertised here. The Better Conversations conference is held every two years. We run communication partner training approximately twice per year.

Just over two weeks until our Better Conversations course in Sydney & three weeks until Perth.

Shouting out to all Speech Pathologists in NSW and WA- we’d love to see you.

And there are places still available!!!

Sign up: www.ucl.ac.uk/brain-scienc...

24.10.2025 08:57 πŸ‘ 7 πŸ” 4 πŸ’¬ 2 πŸ“Œ 0
Preview
Alector Announces Results from Phase 3 INFRONT-3 Trial of Latozinemab for FTD-GRN - FTD Disorders Registry Alector has announced topline results from its Phase 3 INFRONT-3 trial of latozinemab for FTD-GRN.

Alector has announced results from its Phase 3 trial of latozinemab (AL001) for FTD-GRN. While the study did not meet its goals, it offers insight that will guide future FTD research. Thank you to all who participated and continue to advance FTD research. Learn more: ftdregistry.org/press/alecto...

22.10.2025 16:51 πŸ‘ 4 πŸ” 3 πŸ’¬ 0 πŸ“Œ 0
How everyday function, cognition, and behaviour change over time in FTD and PPA - Dr David Foxe
How everyday function, cognition, and behaviour change over time in FTD and PPA - Dr David Foxe YouTube video by FRONTIER FTD Research Group

Recorded videos from our FRONTIER information day are now on our Youtube channel. In this video, David Foxe discusses how everyday function, cognition, and behaviour change over time in FTD and PPA.

www.youtube.com/watch?v=hQWX...

@brainandmindcentre.bsky.social
#endFTD

19.10.2025 05:06 πŸ‘ 2 πŸ” 0 πŸ’¬ 0 πŸ“Œ 0